跳至主要内容
临床试验/CTRI/2025/03/081625
CTRI/2025/03/081625尚未招募不适用

A RANDOMIZED OPEN LABEL CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF SPILANTHES ACMELLA MURR. SUPPOSITORY IN THE MANAGEMENT OF POST-OPERATIVE PAIN IN ANO-RECTAL SURGERIES WITH SPECIAL REFERENCE TO PARTIAL SPHINCTEROTOMY.

Dr YASHASSU T KULOOR1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年3月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Significant reduction in post-operative pain

研究概览

简要总结

1)THIS STUDY HAS BEEN TAKEN UP TO TO EVALUATE THE EFFICACY OF SPILANTHES ACMELLA MURR. SUPPOSITORY IN THE MANAGEMENT OF POST-OPERATIVE PAIN IN ANO-RECTAL SURGERIES WITH SPECIAL REFERENCE TO PARTIAL  SPHINCTEROTOMY

2)THE COMPARISION OF THE STUDY IS WITH DICLOFENAC SUPPOSITORY

3)HYPOTHESIS:-

NULL HYPOTHESIS :-

H0 :- There is no difference in the efficacy of Spilanthes acmella Murr. suppository and Diclofenac sodium suppository in the management of post-operative pain in ano- rectal surgeries with special reference to Partial Sphincterotomy.

ALTERNATE HYPOTHESIS :-

H1 :- The efficacy of Spilanthes acmella Murr. suppository is better than Diclofenac sodium suppository in the management of post-operative pain in ano- rectal surgeries with special reference to Partial Sphincterotomy.

H2 :- The efficacy of Diclofenac sodium suppository is better than Spilanthes acmella Murr. suppository in the management of post-operative pain in ano- rectal surgeries with special reference to Partial sphincterotomy.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
21.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Subjects with post-operative pain who underwent partial sphincterotomy under local anesthesia irrespective of gender, religion, occupation and socio-economic status will be randomly selected for study.
  • Subjects between age group of 21-60 years.
  • Subjects willing to give consent.

排除标准

  • Subjects with a known allergic reaction to Diclofenac sodium.
  • Subjects suffering from infectious diseases like HIV, Hepatitis and Tuberculosis.
  • Immunocompromised subjects.

结局指标

主要结局

Significant reduction in post-operative pain

时间窗: 3 DAYS

次要结局

  • To improve the quality of life.[SF-36](- Generation of in-depth analyzed data on different aspect of the disease.)

研究者

发起方
Dr YASHASSU T KULOOR
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr YASHASSU T KULOOR

SRI SRI COLLEGE OF AYURVEDIC SCIENCE AND RESEARCH

研究点 (1)

Loading locations...

相似试验